Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises CapMan Buyout in connection with the divestment of Malte Månson
Mandate

Vinge advises CapMan Buyout in connection with the divestment of Malte Månson

February 21, 2023 Environmental Law M&A

Vinge advises funds managed by CapMan Buyout and other shareholders of the Malte Månson group in connection with the divestment to Accent Equity.

Founded in 1918, Malte Månson is the leading independent workshop chain for commercial vehicles in Sweden. The Company operates 17 workshops across the country and serves all kinds of commercial vehicles including being authorised for MAN, DAF, Iveco and Mercedes. In 2022 Malte Månson employed approx. 180 employees and generated sales of SEK 360m.

The transaction is subject to applicable competition authorities' approval.

Vinge’s team consisted of Jonas Johansson, Elsie Nassar and Linus Adolfsson (M&A), Johan Cederblad (Environmental) and Julia Hagelberg (Project Assistant).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025